Francis Medical Secures J&J Funding to Expand Vanquish
Maple Grove, Minnesota, United States, November 10, 2026 Francis Medical, Inc., a medical technology company specializing in minimally invasive...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Maple Grove, Minnesota, United States, November 10, 2026 Francis Medical, Inc., a medical technology company specializing in minimally invasive...
Boulder, Colorado, United States, November 10, 2026 Ambrosia Biosciences Inc., a privately held drug discovery company focused on developing...
Boston, Massachusetts, United States, November 10, 2026 Layer Health, a healthcare artificial intelligence (AI) company, has been named a...
Pleasanton, California, United States, and Shanghai, China, November 10, 2026 10x Genomics, Inc., a life science technology company focused...
Yardley, Pennsylvania, United States, November 10, 2026 Jubilant Therapeutics, Inc., a clinical-stage biopharmaceutical company developing precision medicines for myeloproliferative...
Bagsværd, Denmark, November 11, 2026 Novo Nordisk has announced a major USD 200 million funding commitment to the World...
Cambridge, Massachusetts, United States, November 11, 2026 Moderna, Inc. has announced the publication of new real-world comparative effectiveness data...
Shanghai and Nanjing, China, and Pleasanton, California, United States, November 10, 2026 IASO Biotechnology (IASO Bio), a commercial-stage biopharmaceutical...
Aurora, Colorado, United States, November 10, 2026 Researchers at the University of Colorado Anschutz Medical Campus have reported new...
Indianapolis, Indiana, United States, November 10, 2026 Eli Lilly and Company has announced the launch of a new patient-focused...
